Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre Close Period Update 2H FY 2012

9 Jul 2012 07:00

RNS Number : 1712H
PureCircle Limited
09 July 2012
 



9 July 2012

PURECIRCLE LIMITED

("PureCircle" or "the Company")

PRE CLOSE PERIOD UPDATE 2H FY 2012

 

PureCircle (LSE: PURE) the world's largest producer and marketer of high purity stevia today provides a pre close period update in respect of its second half to 30 June 2012 (2H FY 2012). The Company's results statement for the full year FY 2012 will be announced on Thursday 27th September 2012.

Sales

In 2H FY2012 sales are expected to be $30m giving not less than $45m for the full year FY 2012. Whilst 2H sales are double those of 1H FY 2012 they are lower than we wished partly due to the delay in a number of projects now slated for launch in FY 2013; and partly due to the end of the legacy "Take or Pay" volumes and lower sales of Co-products, which reflects the Company's decision to slow down Reb A production in CY 2011 to better align inventories.

Overall high purity stevia volumes increased by more than 20% year-on-year. Within FY 2012 there has been triple digit growth in volumes of proprietary products, including our Natural Flavor TM range and new Natural Sweeteners range. These new products are rapidly winning market share for us and their variable contribution margin percentages are strong. Going forward we believe the improved mix of products will generate large volumes and a much improved base business with better production capacity utilisation.

FY 2012 has seen strong growth in the usage of high purity stevia, boosted by the opening of the important EU market in December 2011 and the reformulations of Sprite, Fanta, Lipton and Nestea being examples of global brands adopting stevia. However, as expected, the growth in usage has not yet fully translated into growth in sales for PureCircle, due to the continued wind-down in Beverage Global Key Account inventories.

FY 2012 was the first year since the beginning of the company's sales history that our sales have not included any contractually pre-committed or "Take or Pay" volumes. We estimate that almost $40m (85%) of sales this year are represented by customer orders and contracts that did not exist three years ago. This provides a good indication of the diversification of our customer base that has been achieved since FY 2009. Further it provides a strong base for sales growth when coupled with Beverage Global Key Account future demand for product, once their inventories are run-down. FY 2012 was also the first year of in-market sales by our Joint Venture companies which provide a good base for future growth in each of their regions.

Margins

The Group expects 2H FY 2012 variable margins to be in line with those reported in 1H FY 2012. With sales at double 1H levels, 2H losses will be lower than 1H FY 2012.

Cashflow and net debt

During 2H FY 2012 the Group has continued to reduce inventories. However with increased receivables due to the doubling of sales volumes, working capital is expected to be higher than at 31 December 2011, resulting in net debt increasing to not more than $80m. The Group funding headroom at the end of FY 2012 is expected to be not less than $44m.

Commenting on the 2H FY 2012 trading update, PureCircle CEO Magomet Malsagov said "Although our FY 2012 sales have been lower than expected due to the delay of a number of projects into FY 2013 and the continued winding down of Beverage Global Key Account inventories; the company still managed to increase year-on-year volumes of High Purity Stevia and Natural Flavors by more than 20%. The underlying usage of high purity stevia continues to grow strongly after the opening of the EU market. The important carbonated soft drink category is beginning to adapt high purity stevia in global mega brands. We have diversified our product portfolio and grown our customer base substantially and each month we get closer to the point where the real size of the market we are building will be evident in our reported sales. Together with our partners we have grown our presence globally to better manage our constantly increasing international customer base.

Through our introduction of innovative products we have successfully eliminated the Company's dependence on one product. Through our direct to market sales strategy we have increased our base of regular customers and repeat sales, with FY 12 being the first time in our history not to include any "Take or Pay" volumes. Going forward this will reduce our sales volatility caused by historic "lumpy" one off sales volumes.

Our innovative product portfolio and scaled supply chain are ready and proven, the measures we are taking to reduce inventories and improve cashflow are fully on track and we have sufficient headroom on our treasury facilities.

Looking forward, we are comfortable with market consensus for sales levels in FY 2013. More detailed guidance for FY 2013 and FY 2014 will be provided in September with our FY 2012 results announcement. Our guidance for high levels of sales remains mid-to-long term based and until then there will continue to be some volatility in our results."

 

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO

+44 7974 005 163

RFC Ambrian Limited Corporate Finance (NOMAD)

+61 8 9480 2500

Steve Allen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBKFDPDBKBCOK
Date   Source Headline
1st Jul 20205:10 pmRNSScheme of Arrangement becomes Effective
30th Jun 20206:00 pmRNSNew External Auditor Appointment
29th Jun 20205:45 pmRNSChanges in the Board Composition
26th Jun 20206:37 pmRNSCourt sanction of the Scheme
18th Jun 20205:47 pmRNSResults of Court Meeting and General Meeting
18th May 20205:45 pmRNSPublication of Scheme Document
7th May 20209:37 amRNSResults of Adjourned 2019 Annual General Meeting
7th May 20207:00 amRNSDispatch Date for Scheme Document
5th May 20202:31 pmRNSPDMR Notification
1st May 20207:00 amRNSBlock Listing Application
29th Apr 20207:00 amRNSNew Banking Facility
28th Apr 20203:22 pmRNSUpdate on Adjourned 2019 Annual General Meeting
20th Apr 20209:04 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:50 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:32 amRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20203:54 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20203:08 pmRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20202:43 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:40 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:35 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:30 pmRNSForm 8.3 - PureCircle Limited
15th Apr 20207:30 amRNSRestoration PureCircle Limited
9th Apr 20204:52 pmRNSNotice of Adjourned AGM and Annual Report
9th Apr 20202:07 pmRNSOffer for PureCircle Limited
9th Apr 20201:56 pmRNSUnaudited Interim Results and Trading Update
5th Mar 20207:00 amRNSCompany Update
5th Mar 20207:00 amRNSManagement Changes
19th Feb 20207:00 amRNSUpdate on lending facilities
10th Feb 20201:25 pmRNSResults of AGM and Directorate Change
4th Feb 20202:46 pmRNSCFO appointment effective
28th Jan 20203:45 pmRNSManagement Update
14th Jan 20204:42 pmRNSNotice of AGM and Company Update
3rd Jan 20202:00 pmRNSAppointment of CFO
2nd Jan 20207:00 amRNSBlock Listing Six Monthly Return
31st Dec 201912:15 pmRNSBoard Changes
27th Dec 20192:50 pmRNSManagement and Board Committee Changes
12th Dec 20192:40 pmRNSBoard and Management Changes
22nd Nov 20193:38 pmRNSResignation of a Director
20th Nov 20197:52 amRNSCorrection: Appointment of Directors
18th Nov 20193:42 pmRNSAppointment of Directors
14th Nov 20197:40 amRNSCompany Update
12th Nov 20192:52 pmRNSResignation of Director
28th Oct 20197:48 amRNSSuspension of share listing
25th Oct 20195:23 pmRNSPostponement of results and suspension of listing
23rd Oct 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:40 pmRNSSecond Price Monitoring Extn
20th Sep 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:15 pmRNSPostponement of Results
22nd Aug 20194:35 pmRNSPrice Monitoring Extension
16th Aug 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.